# Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors

> **NCT00884676** · PHASE1 · COMPLETED · sponsor: **Jaime Merchan** · enrollment: 36 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** Ixabepilone
- **DRUG:** Sunitinib

## Key facts

- **NCT ID:** NCT00884676
- **Lead sponsor:** Jaime Merchan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2013-11
- **Final completion:** 2015-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-10-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00884676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00884676, "Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00884676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*